bioMérieux S.A. is a global leader in the field of in vitro diagnostics, providing essential solutions to detect and manage infectious diseases, cardiovascular emergencies, and oncology. The company's... bioMérieux S.A. is a global leader in the field of in vitro diagnostics, providing essential solutions to detect and manage infectious diseases, cardiovascular emergencies, and oncology. The company's primary function centers around developing and marketing tests that identify pathogens, track disease progression, and guide critical healthcare decisions. Distinguished by their innovation in the diagnostics industry, bioMérieux's offerings significantly impact sectors like public health, food safety, and pharmaceuticals by improving the speed and accuracy of laboratory results. Their product range includes automated systems and high-precision reagents used in clinical and industrial applications, thus facilitating operational efficiency and patient care efficiency. Founded in 1963 and headquartered in Marcy-l'Étoile, France, bioMérieux integrates research and development expertise to enhance global health outcomes, demonstrating a strong commitment to quality and technological advancement. Their role in the marketplace is pivotal, not only providing indispensable tools for healthcare professionals globally but also supporting rigorous standards in safety and regulatory compliance across industries.
In 2024, Biomerieux was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Biomerieux has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Biomerieux are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Turnover
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Opex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Capex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
6.5 CCM/CCA - Transport by motorbikes, passenger cars and light commercial vehicles
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
7.3 CCM/CCA - Installation, maintenance and repair of energy efficiency equipment
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Biomerieux’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to 2022.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Biomerieux’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biomerieux’s data sources below and access millions more through our Disclosure Search.
a. Biomerieux's Universal Registration Document (URD) 2024
b. Biomerieux's Universal Registration Document (URD) 2023
c. Biomerieux's Universal Registration Document (URD) 2022
Insights into Biomerieux's Revenues from Sustainable Activities
In 2024, Biomerieux reported EU Taxonomy-eligible revenues of EUR 526.60 million, representing 13.2% of its total turnover. Of this amount, EUR 0 of Biomerieux's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Insights into Biomerieux's CAPEX from Sustainable Activities
In 2024, Biomerieux reported EU Taxonomy-eligible CAPEX of EUR 227.53 million,representing 56.7% of its total CAPEX. Of this amount, EUR 310,000 of Biomerieux's CAPEX was classified as EU Taxonomy-aligned, indicating that 0.1% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Biomerieux's Taxonomy-Eligible Capex Over Time
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
Have Biomerieux's increased its investment in sustainable activities over time?
Compared to the previous year (2023), Biomerieux's taxonomy-aligned CAPEX decreased by 93.33%,suggesting that Biomerieux may have scaled back investments in sustainable projects, reprioritized its capital deployment, or reduced transparency in its taxonomy-aligned disclosures.a, b
How much of Biomerieux's capital expenditure (CAPEX) is eligible under the EU Taxonomy?
In 2024, Biomerieux reported that EUR 227.53 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 56.7% of the company's total CAPEX. Of this amount, EUR 310,000 (0.1% of total CAPEX) was classified as Taxonomy-aligned. This means that 56.6% of Biomerieux's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Biomerieux's eligible CAPEX is aligned with the EU Taxonomy?
In 2024, Biomerieux reported that EUR 310,000 of its CAPEX was aligned under the EU Taxonomy, representing 0.1% of its total capital investment.a
This low alignment reflects that Biomerieux is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.
Biomerieux's Eligibility & Alignment Overview
Biomerieux's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
How is Biomerieux's taxonomy-aligned CAPEX distributed across the EU environmental objectives?
In 2024, Biomerieux reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.1%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%
How much Biomerieux is investing in climate-related solutions?
In 2024, Biomerieux allocated EUR 401,290 of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.1% of the company's total capital expenditure,indicating that Biomerieuxhas only marginally directed its capital expenditure toward climate-related activities, suggesting limited alignment with climate objectives.a
Insights into Biomerieux's OPEX from Sustainable Activities
In 2024, Biomerieux reported EU Taxonomy-eligible OPEX of EUR 0,representing 0% of its total operating expenses (OPEX). Of this amount, EUR 0 of Biomerieux's OPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Want Full Access to Biomerieux's EU Taxonomy Dataset?
b
b
a
b
c
b
b
a
b
b
a
b
b